According to a new report North America Fusion Biopsy Market, published by KBV research, the North America Fusion Biopsy Market would witness market growth of 10.7% CAGR during the forecast period (2020-2026).
The USA market dominated the North America Fusion Biopsy Market by Country in 2019, growing at a CAGR of 10.3 % during the forecast period. The Canada market is experiencing a CAGR of 11.1% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 13.2% during (2020 - 2026).
The Transrectal market dominated the Canada Fusion Biopsy Market by Route in 2019, and would continue to be a dominant market till 2026. The Transperineal market is expected to witness highest CAGR of 17% during (2020 - 2026).
The Hospitals market dominated the Mexico Fusion Biopsy Market by End Users in 2019, growing at a CAGR of 12.6 % during the forecast period. The Ambulatory care centers market is estimated to grow at a CAGR of 15.5% during (2020 - 2026).
Report Structural Insights: https://www.kbvresearch.com/north-america-fusion-biopsy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
By End Use
By Route
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
